Paul R Kirchgraber Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Paul R Kirchgraber.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Paul R Kirchgraber. Paul R Kirchgraber is a CEO, Covance Drug Development in LABORATORY CORP OF AMERICA HOLDINGS ($LH).
Address: 531 SOUTH SPRING STREET BURLINGTON 27215 NC
Companies in which Paul R Kirchgraber is an Insider
LABORATORY CORP OF AMERICA HOLDINGS
Industry: SERVICES-MEDICAL LABORATORIES [8071]
Position of Paul R Kirchgraber: CEO, Covance Drug Development
Holdings: 7,844 shares
Current Value: $1,018,622
Latest Transaction: May 10 2021
$LH Market Capitalization: $13.45B
$LH Previous Close: $129.86
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Paul R Kirchgraber
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 10 2021 | LH | LABORATORY CORP OF ... | Kirchgraber Paul R | CEO, Covance Drug D ... | Sell | S | 276.55 | 2,500 | 691,375 | 7,844 | 10.3 K to 7.8 K (-24.17 %) |
| Apr 06 2021 | LH | LABORATORY CORP OF ... | Kirchgraber Paul R | CEO, Covance Drug D ... | Option Exercise | M | 0.00 | 1,010 | 0 | 6,781 | |
| Apr 06 2021 | LH | LABORATORY CORP OF ... | Kirchgraber Paul R | CEO, Covance Drug D ... | Payment of Exercise | F | 252.67 | 452 | 114,207 | 10,344 | 10.8 K to 10.3 K (-4.19 %) |
| Apr 06 2021 | LH | LABORATORY CORP OF ... | Kirchgraber Paul R | CEO, Covance Drug D ... | Buy | M | 0.00 | 1,010 | 0 | 10,796 | 9.8 K to 10.8 K (+10.32 %) |
| Mar 30 2021 | LH | LABORATORY CORP OF ... | Kirchgraber Paul R | CEO, Covance Drug D ... | Payment of Exercise | F | 251.58 | 790 | 198,748 | 9,786 | 10.6 K to 9.8 K (-7.47 %) |
| Mar 30 2021 | LH | LABORATORY CORP OF ... | Kirchgraber Paul R | CEO, Covance Drug D ... | Grant | A | 0.00 | 2,104 | 0 | 10,576 | 8.5 K to 10.6 K (+24.83 %) |
| Feb 17 2021 | LH | LABORATORY CORP OF ... | Kirchgraber Paul R | CEO, Covance Drug D ... | Option Exercise | M | 0.00 | 317 | 0 | 7,791 |